A fetal stress test is a monitoring procedure used during pregnancy to check how well a baby’s heart responds to movement or contractions, giving clinicians a window into whether the baby is getting enough oxygen. The most common version, the non-stress test, simply records the fetal heart rate while the baby moves on its own. A less common variant, the contraction stress test, goes a step further by observing the heart rate during uterine contractions. These tests are typically ordered in the third trimester when a pregnancy carries extra risk, and they help guide decisions about timing delivery or stepping up surveillance.
How the Non-Stress Test Works
The non-stress test, or NST, is about as low-key as medical testing gets. You sit in a reclining chair (or lie on your side), and a clinician straps two sensors to your abdomen. One tracks the fetal heart rate, the other picks up any uterine contractions. The whole thing usually takes about 20 minutes. There are no needles, no medications, and nothing invasive happening to you or the baby. The test works by recording whether the baby’s heart rate speeds up when the baby moves, which is a healthy sign that the nervous system is functioning well.1PubMed Central. Do different positions during a non-stress test affect the maternofetal physiological parameters and comfort in pregnant women?
A “reactive” result means the baby’s heart rate rose by at least 15 beats per minute above baseline, lasting at least 15 seconds, at least twice during the 20-minute window. That pattern is reassuring because it reflects a baby whose brain, heart, and nervous system are coordinating properly. A “non-reactive” result means those accelerations did not happen, which does not automatically mean something is wrong but does prompt further evaluation.1PubMed Central. Do different positions during a non-stress test affect the maternofetal physiological parameters and comfort in pregnant women?
Why These Tests Get Ordered
Fetal stress tests are not routine for every pregnancy. They are reserved for situations where something about the pregnancy puts the baby at higher-than-normal risk of problems with oxygen delivery or growth. In a large randomized trial, the most common reasons for ordering fetal assessment were going past the due date (about 43% of cases), decreased fetal movement (22%), diabetes (11%), high blood pressure (10%), and suspected growth restriction (7%).2PubMed. Screening for fetal well-being in a high-risk pregnant population comparing the nonstress test with umbilical artery Doppler velocimetry: a randomized controlled clinical trial Other triggers include a history of stillbirth, multiple gestation, certain placental abnormalities, and conditions affecting blood flow to the uterus.
The underlying logic is straightforward. A healthy placenta delivers oxygen-rich blood to the baby around the clock. When conditions like diabetes or preeclampsia impair that delivery, the baby can gradually become oxygen-deprived. Fetal heart rate monitoring picks up early signs of that stress before it becomes dangerous. In animal research, experimentally reducing blood flow to the uterus produces a characteristic delayed drop in fetal heart rate, a pattern clinicians call a “late deceleration,” which signals the baby is not tolerating reduced oxygen well.3American Journal of Obstetrics and Gynecology. Mechanisms of late decelerations of the fetal heart rate during hypoxia The stress tests are designed to catch that kind of signal in a clinical setting.
The Contraction Stress Test
The contraction stress test, or CST, takes a different approach. Instead of passively waiting to see what the baby’s heart does during natural movement, it observes the heart rate while the uterus contracts. Contractions temporarily squeeze the blood vessels supplying the placenta, so a baby that is already marginal on oxygen will show heart rate dips (late decelerations) in response. A healthy baby tolerates contractions without those drops.
Contractions can be triggered in a couple of ways. One method involves low-dose intravenous oxytocin, sometimes called the “oxytocin challenge test.” A simpler and faster alternative is nipple stimulation, which causes your body to release its own oxytocin. In one study that compared these methods over a year, nipple stimulation produced no cases of uterine overstimulation and significantly shortened the time needed to complete the test compared to intravenous oxytocin.4PubMed. Contraction stress test by nipple stimulation: efficacy and safety
A “negative” CST result, confusingly, is the good outcome. It means no late decelerations occurred during contractions, suggesting the baby can handle the stress of labor. A “positive” result (late decelerations with most contractions) raises concern. Early research on the CST found that a negative result was a reliable indicator that the baby could tolerate labor if delivery happened within the following week.5PubMed. Contraction stress test for antepartum fetal evaluation Because the CST is more time-consuming, more invasive, and carries at least a theoretical risk of triggering preterm labor, most clinicians now reach for the NST first and reserve the CST for cases where more information is needed.
The Biophysical Profile
When an NST comes back non-reactive or when clinicians want a more complete picture, the biophysical profile (BPP) is often the next step. The BPP combines the heart rate monitoring of a standard NST with an ultrasound that evaluates four additional things: fetal movement, fetal muscle tone, fetal breathing movements, and the volume of amniotic fluid surrounding the baby.6PubMed Central. Biophysical profile for fetal assessment in high risk pregnancies Each component gets scored, and the combined score helps clinicians gauge how well the baby is doing.
A modified version of the BPP is sometimes used as a first-pass screening. The modified BPP pairs the NST with just one ultrasound measurement: amniotic fluid volume. If this shorter assessment raises any concerns, the full five-component BPP follows.7PubMed Central. Biophysical profile for fetal assessment in high risk pregnancies – Section: Plain language summary During the modified BPP, amniotic fluid is assessed either by measuring the single deepest pocket of fluid or by calculating a broader amniotic fluid index.8PubMed. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial
The BPP’s strength is that it looks at the baby from multiple angles at once. A baby might have a temporarily quiet heart rate trace (producing a non-reactive NST) but still show normal breathing, movement, and fluid levels on ultrasound, which together paint a reassuring picture. The more components that look abnormal, the more concerned clinicians become.
The Problem with False Alarms
One of the most important things to understand about fetal stress tests is that they are much better at telling you the baby is fine than they are at telling you the baby is in trouble. Both the NST and the CST have high false-positive rates, meaning they frequently flag problems that turn out not to exist.9PubMed. Assessing the diagnostic accuracy and efficacy of selected antepartum fetal surveillance techniques A non-reactive NST might simply mean the baby was sleeping during the test.
Fetal sleep cycles are actually the most common reason for a non-reactive result. Babies cycle between active and quiet states in the womb, and during a quiet period, heart rate accelerations naturally decrease or disappear. A sleep cycle can last 20 to 40 minutes, which is exactly the duration of the test. That is why a non-reactive NST is usually repeated or extended rather than immediately treated as alarming.10PubMed Central. Decreasing the Duration of Point of Decision to Getting Non-stress Test Done: A Quality Improvement Study Clinicians sometimes try to wake the baby with a gentle acoustic stimulus or by having you drink something cold and sugary.
This high false-positive rate matters because it can lead to unnecessary interventions like emergency cesarean deliveries or premature inductions. The challenge in obstetrics is balancing vigilance against overreaction. A reassuring test provides strong comfort. An abnormal test triggers more testing, not immediate delivery in most cases.
When Gestational Age Changes the Picture
The criteria for a “reactive” NST assume a certain level of neurological maturity in the baby. Before about 32 weeks of gestation, the fetal nervous system is still developing, and heart rate accelerations are naturally smaller and shorter. Research shows that as many as half of fetuses between 24 and 28 weeks will produce a non-reactive NST simply because their nervous systems are not mature enough yet, not because anything is wrong.11American Journal of Obstetrics and Gynecology. The non-stress test (NST) is the most widely used tool for fetal assessment
To account for this, guidelines from the National Institute of Child Health and Human Development define reassuring accelerations before 32 weeks as a rise of just 10 beats per minute lasting 10 seconds, rather than the standard 15-by-15 threshold used later in pregnancy.11American Journal of Obstetrics and Gynecology. The non-stress test (NST) is the most widely used tool for fetal assessment Without that adjustment, an enormous number of preterm babies would be falsely labeled as non-reactive, leading to unnecessary worry and interventions.
What Happens After an Abnormal Result
An abnormal NST does not automatically send you to the delivery room. In a study of over 2,100 outpatient non-stress tests, about 5% came back abnormal and required urgent clinical follow-up. Of those patients with abnormal results, only about 2% delivered within 24 hours.12PubMed Central. Urgent follow up after outpatient non-stress tests and the potential for fetal monitoring at home The rest underwent additional evaluation, such as a BPP, extended monitoring, or repeat testing, and most were cleared to continue the pregnancy with closer surveillance.
The clinical path after an abnormal result depends on the full context. How far along is the pregnancy? What was the original reason for testing? Is the amniotic fluid volume normal? Are there other signs of compromise? A mildly non-reactive NST at 37 weeks in a patient with well-controlled diabetes might simply be repeated the next day. A non-reactive NST at 39 weeks with low amniotic fluid and high blood pressure might trigger a conversation about induction. The stress test provides one piece of information that feeds into a much larger decision-making process.
How Fetal Stress Tests Compare to Doppler Ultrasound
Fetal heart rate monitoring is not the only way to evaluate a baby’s well-being. Doppler ultrasound, which measures blood flow velocity in the umbilical cord and other fetal blood vessels, has emerged as a complementary tool. For babies with suspected growth restriction, Doppler measurements of blood flow in the umbilical artery and fetal carotid artery have actually proven more predictive of later distress during labor than either the NST or the CST.13Fetal Diagnosis and Therapy. Prediction of Fetal Distress and Poor Outcome in Intrauterine Growth Retardation – A Comparison of Fetal Heart Rate Monitoring Combined with Stress Tests and Doppler Ultrasound
That same research suggested that for growth-restricted babies specifically, stressful examinations like the CST could be replaced by Doppler assessment, which is painless and does not provoke contractions. In the broader population of high-risk pregnancies, however, the NST remains widely used because it is simple, fast, and inexpensive. The two approaches are not mutually exclusive. A clinician managing a complex case might use both an NST and Doppler measurements at different points in the surveillance plan.
Does Cardiotocography Actually Improve Outcomes?
The broader category of fetal heart rate monitoring during pregnancy is called antenatal cardiotocography (CTG), and the evidence on whether it prevents bad outcomes is surprisingly mixed. A Cochrane systematic review comparing traditional CTG monitoring to no CTG in high-risk pregnancies found no significant difference in perinatal deaths, though the studies were small and the review acknowledged it was underpowered to draw firm conclusions.14PubMed Central. Antenatal cardiotocography for fetal assessment
Where the evidence is stronger is in how the monitoring is interpreted. That same review found that computerized CTG analysis, where software rather than a human reads the trace, was associated with significantly fewer perinatal deaths compared to traditional visual interpretation by clinicians. The reduction was dramatic in the two trials that tested this: roughly a fivefold decrease in mortality in the computerized group.14PubMed Central. Antenatal cardiotocography for fetal assessment This points to a pattern common across obstetric monitoring: the tool itself matters less than how consistently and accurately the data is read.
How Often and How Many
Testing frequency depends on the clinical situation. Some patients get a weekly NST; others are monitored twice a week. Cost-effectiveness research on pregnancies with advanced maternal age modeled the trade-offs between these frequencies. Twice-weekly NSTs generated far more positive results (and thus more interventions) but also prevented more stillbirths than once-weekly testing. The twice-weekly approach remained cost-effective as long as the per-test cost stayed below roughly $360.15American Journal of Obstetrics and Gynecology. Cost-effectiveness of antepartum surveillance strategies in advanced maternal age
For high-risk pregnancies, the math tilts toward more frequent monitoring. For borderline-risk situations, the equation is less clear. Every additional test increases the chance of a false positive, which can cascade into more testing, more anxiety, and sometimes unnecessary early delivery. Clinicians weigh the specific risk profile of each pregnancy when deciding on a surveillance schedule.
The Anxiety of Being Monitored
Being told you need fetal monitoring is inherently stressful, and the testing process itself can amplify that anxiety. A quasi-experimental study found that pregnant women had measurably elevated anxiety scores before and during non-stress tests. Playing music during the procedure significantly reduced state anxiety compared to undergoing the test without music, with anxiety scores dropping from an average of about 31 to about 28 in the music group.16European Journal of Midwifery. Music intervention during non-stress test and its effects on maternal anxiety, maternal vital signs and fetal parameters: A quasi-experimental study
The anxiety piece matters beyond the test itself. Patients who receive a non-reactive result often spend hours or days in heightened worry, even if the follow-up is reassuring. The emotional weight of false-positive results is one of the underappreciated costs of fetal surveillance. Some clinicians now spend more time before testing explaining the high likelihood of a normal result and the common reasons (like sleep cycles) for temporary non-reactivity, which helps frame an ambiguous result as expected rather than alarming.
Remote and Home-Based Monitoring
The COVID-19 pandemic accelerated interest in whether fetal heart rate monitoring could be done at home rather than in a clinic. A wireless, self-guided fetal heart rate monitor tested in both hospital and home settings showed strong agreement with standard cardiotocography equipment, staying well within an acceptable margin of 8 beats per minute. Pregnant women were able to obtain usable recordings 97% of the time without clinician assistance, and the device scored in the top percentiles for usability and satisfaction.17PubMed Central. Accuracy, Clinical Utility, and Usability of a Wireless Self-Guided Fetal Heart Rate Monitor
A recent systematic review and meta-analysis of randomized trials comparing remote fetal heart rate monitoring to conventional in-person monitoring found no differences in key outcomes like five-minute Apgar scores below seven or cesarean delivery rates.18PubMed. Remote and home-based fetal heart rate monitoring for fetal surveillance compared with conventional in-person monitoring: a systematic review and meta-analysis of randomized controlled trials In other words, having the test done at home did not appear to make it less safe. For patients who live far from their clinic or who find frequent office visits burdensome, remote monitoring could reduce the logistical barrier to staying on a twice-weekly schedule. Still, these devices are designed for pregnancies where the level of risk calls for periodic check-ins rather than continuous in-hospital surveillance. A patient whose baby is in acute distress still needs to be in a setting where immediate delivery is possible.
The technology is also raising questions about what “fetal stress testing” will look like in the future. If wearable monitors eventually enable continuous or near-continuous home recording, the entire paradigm of intermittent testing could shift. Rather than asking a snapshot question once or twice a week, clinicians might have access to days of data, with algorithms flagging patterns that merit attention. That transition is not imminent, but the building blocks are already being studied.